B1G Numbers, April 2026 | Exchanges
The April 2026 edition of B1G Numbers highlighted key performance metrics for SIX Swiss Exchange and Spain’s IBEX 35, focusing on listings, index movements, and trading turnover. The report opened with Sentiel’s multi‑exchange debut on April 17, securing a CHF 261 million market capitalization, underscoring confidence in the platform amid a challenging market. Both blue‑chip indices posted gains: the Swiss SMI rose 2.8% while Spain’s IBEX 35 climbed 4.3% for the month, leaving the SMI 1% below its YTD start and the IBEX up 2.7% YTD. Trading volumes slipped relative to March due to a shorter month, yet fixed‑income turnover surged—Switzerland’s total reached CHF 12 bn (+2.9% YoY) and Spain’s nearly doubled to €13 bn (+96.2%). A standout achievement was the structure‑product segment, which logged 28,700 new listings, pushing cumulative listings to roughly 109,000—well beyond the 100,000 milestone and marking a 73% increase over the record year of 2025. Spain also recorded its highest non‑display liquidity pool turnover, with €6‑6.5 million traded on April 16‑17, mirroring the success of the Swiss admit offering model. These figures signal robust investor appetite for diversified products and reinforce SIX and IBEX as attractive venues for technology and fixed‑income issuers. The continued growth in listings and turnover suggests expanding market depth, offering participants broader access to capital and liquidity across Europe.
Centiel Listed on SIX Swiss Exchange – IPO 2026
The video celebrates Sentiel's debut on SIX Swiss Exchange, marking its IPO and first day of trading. The ceremony underscores the company's transition from a private startup to a publicly listed entity. Founder Filippo Giarratana recounts an 11‑year evolution built on...
SIX Goes to Europe
SIX Group outlined its strategic push to become a pan‑European trading infrastructure provider, highlighted by recent acquisitions of Spain’s BME and the UK‑based Aquis. The moves extend its traditional Swiss exchange roots into key markets, allowing the firm to offer...
Post-Quantum Security: How the Swiss Payment Transactions System Is Protecting Itself
The video focuses on how SIX, Switzerland’s payment‑system operator, is preparing its infrastructure for the post‑quantum era. Christian Bühler explains that while symmetric schemes like AES remain strong, today’s asymmetric algorithms are vulnerable to future quantum attacks, prompting a shift...
Interoperability Is an Essential Aspect of Advancing Blockchain Technology Adoption
The video emphasizes that interoperability has become a mega‑trend essential for scaling blockchain technology, linking both digital‑asset ecosystems and the traditional financial world. The speaker argues that seamless cross‑chain communication expands market reach, allowing participants to move beyond the limited crypto...
How SIX Is Leveraging Institutional Confidence in Blockchain Technology?
The video outlines how SIX Swiss Exchange, through its digital arm SDX, is capitalising on growing institutional confidence in blockchain technology to expand its service offering. Across the globe, financial market infrastructures and banks are rolling out blockchain‑enabled services. Both buy‑side...
DebiX+ Explanatory Video
The debiX+ explanatory video walks cardholders through downloading the app, creating a profile, and enrolling in 3‑D Secure. It also demonstrates how to set a personal identification number (PIN), adjust security settings, and configure spending limits. Additional sections cover online...
Open Banking Exchange 2026
The Open Banking Exchange 2026, the fourth edition of the annual gathering, convened in Zurich to celebrate openness, collaboration, and the latest trends in Open Finance. More than 200 industry professionals, from major cantonal banks to agile fintechs, attended the...
IPO Anniversary BioVersys at SIX
BioVersys commemorated its first anniversary on the SIX Swiss Exchange, reaffirming its mission to combat drug‑resistant bacterial infections. The company highlighted how antibiotic resistance now jeopardizes advances such as oncology therapies, underscoring the urgency of new antibiotics. The listing has amplified...